Filing Details
- Accession Number:
- 0001209191-15-055077
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-06-19 16:15:45
- Reporting Period:
- 2015-03-16
- Filing Date:
- 2015-06-19
- Accepted Time:
- 2015-06-19 16:15:45
- Original Submission Date:
- 2015-03-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375151 | Zogenix Inc. | ZGNX | Pharmaceutical Preparations (2834) | 205300780 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1257386 | Roger Hawley | C/O Zogenix, Inc. 12400 High Bluff Dr., Suite 650 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-16 | 140,000 | $1.31 | 1,344,447 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $1.305 to $1.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The reporting person's original Form 4 reported this transaction using the incorrect transaction code.
Billionaire Hedge Funds
